The Canadian Venture Capital (VC) market has experienced a significant decline, with investment levels hitting their lowest point since the onset of the COVID-19 pandemic in 2020. According to the Canadian Venture Capital & Private Equity Association (CVCA), $2.9 billion CAD was deployed across 254 deals in the first half of 2025, marking a 26% drop in investment dollars and a 22% decline in deal count compared to the same period last year. The challenging macroeconomic conditions have made it difficult for Canadian tech startups and VC firms to raise capital, resulting in fewer mega-deals and reduced U.S. investor participation. Despite the overall decline, life sciences and venture debt have emerged as bright spots, with significant investment growth. Manitoba also saw a notable increase in VC funding. However, the private equity market in Canada continues to thrive, with record-breaking investments in the first half of 2025.<\/p>\n","protected":false},"excerpt":{"rendered":"
The Canadian Venture Capital (VC) market has experienced a significant decline, with investment levels hitting their lowest point since the onset of the COVID-19 pandemic in 2020. According to the…<\/p>\n","protected":false},"author":1,"featured_media":951,"comment_status":"","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[178],"tags":[414,1149,5872,267,2191],"class_list":["post-10110","post","type-post","status-publish","format-standard","has-post-thumbnail","category-canada","tag-canada-startup-news","tag-life-sciences","tag-manitoba","tag-venture-capital","tag-venture-debt"],"acf":[],"yoast_head":"\n